计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| P648498-5mg |
5mg |
期货 ![]() |
| |
| P648498-10mg |
10mg |
期货 ![]() |
| |
| P648498-25mg |
25mg |
期货 ![]() |
| |
| P648498-50mg |
50mg |
期货 ![]() |
|
| 别名 | PDE9-合一 |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | PDE9-IN-1 |
| 生化机理 | PDE9-IN-1 是一种强效、选择性和口服生物利用型磷酸二酯酶-9A(PDE9A)抑制剂,其 IC 50 为 8.7 nM。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
PDE9-IN-1 is a potent, selective, and orally bioavailable phosphodiesterase-9A (PDE9A) Inhibitor with an IC 50 of 8.7 nM In Vitro PDE9-IN-1 is excellent selectivity across PDE families. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo PDE9-IN-1 (2.5 and 5.0 mg/kg; Oral administration; daily for 21 days) effectively recovers learning and memory function . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Unilateral common carotid artery occlusion (UCCAO) mouse model Dosage: 2.5 and 5.0 mg/kg Administration: Oral administration; daily for 21 days Result: Significantly reduced the day 6 escape latency time and increased the frequency of platform area crossings, and recovered learning and memory function. High dose group possibly improved the escape latency time of mice. Form:Solid IC50& Target:PDE9A 8.7 nM (IC 50 ) |
| 纯度 | ≥99% |
| 分子量 | 362.40 |
|---|
| 溶解性 | DMSO : 100 mg/mL (275.94 mM; Need ultrasonic) |
|---|